Science and Medical Affairs Advisor
Ian joined Ferghana in 2017 to provide advice on the science and clinical programs of clients and prospective clients due to his wide industry, research and medical practice background.
Ian started his career as a National Health Service hospital doctor in Endocrinology and Clinical Biochemistry. He then joined the pharmaceutical industry, managing key registration studies for mifepristone in the UK for Roussel and meloxicam in Europe for Boehringer Ingelheim. Thereafter Ian became International Medical Director for Laboratorios Almirall. Ian went to South Africa as a Senior Management Consultant in Healthcare with Michael Porter’s Monitor Group, working on restructuring State Hospitals for the newly democratic South Africa. He was then asked to join Mandela’s Government as a Special Advisor In Health. While in government there, Ian represented South Africa at binational negotiations on healthcare and pharmaceuticals with the USA, Australia, Cuba, Denmark, European Union, and SADC; multilateral forums [such as WHO/WHA, WTO, UNAIDS, USTR, TDA, and USAID, US patent office, DTI, DFID and with NGO’s: ACT-UP, MSF], In 2000, Ian set up his own consultancy working with Pfizer; the Adam Smith Institute; the World Bank; Investment Banks, start-up biotechnology companies. Ian also kept a part-time practice for the NHS, the New Zealand Military and NZ Health Service and Otago University.
Ian qualified in Medicine in Scotland and has a first class hons degree in Medical Biochemistry and a Master of Science in Clinical Biochemistry. He has a Masters degree in Management from London Business School. Ian currently serves as an elected Governor on the Oxford University Hospitals NHS Trust and as a Councillor in Wheatley Parish.